Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: IMarkHD: in Vivo Longitudinal Imaging of HD Pathology

View source ↗

Summary

Clinical trial update on the IMarkHD study, which investigates in vivo longitudinal imaging of Huntington's disease pathology. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: King's College London | Conditions: Huntington Disease | Status: RECRUITING